Literature DB >> 3081158

Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.

J R Robertson, A B Bucknall, P D Welsby, J J Roberts, J M Inglis, J F Peutherer, R P Brettle.   

Abstract

Stored blood samples from 164 intravenous drug abusers who attended a Scottish general practice were tested for HTLV-III/LAV (human T cell lymphotropic virus type III/lymphadenopathy associated virus) infection. Of those tested, 83 (51%) were seropositive, which is well above the prevalence reported elsewhere in Britain and Europe and approaches that observed in New York City. The timing of taking samples of negative sera and continued drug use suggest that as many as 85% of this population might now be infected. The infection became epidemic in late 1983 and early 1984, thereafter becoming endemic. The practice of sharing needles and syringes correlated with seropositivity, which, combined with the almost exclusive intravenous use of heroin and other behavioural patterns, may explain the high prevalence of HTLV-III/LAV infection in the area. Rapid and aggressive intervention is needed to control the spread of infection.

Entities:  

Mesh:

Year:  1986        PMID: 3081158      PMCID: PMC1339512          DOI: 10.1136/bmj.292.6519.527

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  60 in total

1.  An integrated framework for the inference of viral population history from reconstructed genealogies.

Authors:  O G Pybus; A Rambaut; P H Harvey
Journal:  Genetics       Date:  2000-07       Impact factor: 4.562

2.  A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.

Authors:  K S Froebel; G M Raab; C D'Alessandro; M P Armitage; K M MacKenzie; M Struthers; J M Whitelaw; S Yang
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

3.  Legal needle buying in St. Louis.

Authors:  W M Compton; L B Cottler; S H Decker; D Mager; R Stringfellow
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

4.  After the epidemic: follow up study of HIV seroprevalence and changing patterns of drug use.

Authors:  C A Skidmore; J R Robertson; A A Robertson; R A Elton
Journal:  BMJ       Date:  1990-01-27

5.  Prevalence of HIV among childbearing women and women having termination of pregnancy: multidisciplinary steering group study.

Authors:  D J Goldberg; H MacKinnon; R Smith; N B Patel; J B Scrimgeour; J M Inglis; J F Peutherer; G E Urquhart; J A Emslie; R G Covell
Journal:  BMJ       Date:  1992-04-25

6.  Prevalence of HIV infection among drug users in Edinburgh.

Authors:  P J Ronald; J R Robertson
Journal:  BMJ       Date:  1992-06-06

Review 7.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

8.  Human immunodeficiency virus in drug misusers and increased consultation in general practice.

Authors:  J J Roberts; C A Skidmore; J R Robertson
Journal:  J R Coll Gen Pract       Date:  1989-09

Review 9.  Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done.

Authors:  D C Des Jarlais; S R Friedman
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis.

Authors:  Manon Ragonnet-Cronin; Celia Jackson; Amanda Bradley-Stewart; Celia Aitken; Andrew McAuley; Norah Palmateer; Rory Gunson; David Goldberg; Catriona Milosevic; Andrew J Leigh Brown
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.